Howard L Weiner, MD
Affiliations: | 1985- | Neurology | Harvard Medical School - Brigham and Women's Hospital |
Area:
Multiple SclerosisWebsite:
http://weinerlab.bwh.harvard.edu/?page_id=154Google:
"Howard Weiner"Mean distance: (not calculated yet)
Children
Sign in to add trainee
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Zurawski J, Tauhid S, Chu R, et al. (2019) 7T MRI cerebral leptomeningeal enhancement is common in relapsing-remitting multiple sclerosis and is associated with cortical and thalamic lesions. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458519885106 |
| Palotai M, Nazeri A, Cavallari M, et al. (2019) History of fatigue in multiple sclerosis is associated with grey matter atrophy. Scientific Reports. 9: 14781 |
| Rezende RM, Nakagaki BN, Moreira TG, et al. (2019) γδ T Cell-Secreted XCL1 Mediates Anti-CD3-Induced Oral Tolerance. Journal of Immunology (Baltimore, Md. : 1950) |
| Garo LP, Ajay AK, Fujiwara M, et al. (2019) Smad7 Controls Immunoregulatory PDL2/1-PD1 Signaling in Intestinal Inflammation and Autoimmunity. Cell Reports. 28: 3353-3366.e5 |
| Singhal T, O'Connor K, Dubey S, et al. (2019) Gray matter microglial activation in relapsing vs progressive MS: A [F-18]PBR06-PET study. Neurology(R) Neuroimmunology & Neuroinflammation. 6 |
| Rezende RM, Lopes ME, Menezes GB, et al. (2019) Visualizing Lymph Node Structure and Cellular Localization using Ex-Vivo Confocal Microscopy. Journal of Visualized Experiments : Jove |
| Palotai M, Cavallari M, Koubiyr I, et al. (2019) Microstructural fronto-striatal and temporo-insular alterations are associated with fatigue in patients with multiple sclerosis independent of white matter lesion load and depression. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458519869185 |
| Yano H, Gonzalez C, Healy BC, et al. (2019) Discontinuation of disease-modifying therapy for patients with relapsing-remitting multiple sclerosis: Effect on clinical and MRI outcomes. Multiple Sclerosis and Related Disorders. 35: 119-127 |
| Singhal T, O'Connor K, Dubey S, et al. (2019) Gray matter microglial activation in relapsing vs progressive MS: A [F-18]PBR06-PET study. Neurology(R) Neuroimmunology & Neuroinflammation. 6: e587 |
| Peroni S, Sorosina M, Malhotra S, et al. (2019) A pharmacogenetic study implicates in the response to Interferon-β in multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458519851428 |